These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4599446)

  • 1. [Therapy of ulcerous disease with a preparation of colloidal bismuth].
    Marano R; Nacchiero M; Martino Bonomo G
    Clin Ter; 1974 Apr; 69(2):113-31. PubMed ID: 4599446
    [No Abstract]   [Full Text] [Related]  

  • 2. Pilot trial of a colloidal bismuth preparation in the treatment of peptic ulcer.
    Weiss G; Kallmeyer JC
    S Afr Med J; 1968 Mar; 42(13):317-20. PubMed ID: 4869603
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vicalin in the treatment of gastroduodenal ulcer].
    Ljubojević S; Hadzijahić H; Perinović M; Grujić M; Rizvanbegović B; Bratović I; Nikolić J
    Med Arh; 1974; 28(5):511-4. PubMed ID: 4615219
    [No Abstract]   [Full Text] [Related]  

  • 4. A double blind evaluation of the effect of tri-potassium di-citrato bismuthate in peptic ulcer.
    Poulantzas J; Polymeropoulos PS; Papasomatious A
    Br J Clin Pract; 1978 May; 32(5):147-8. PubMed ID: 352384
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical, radiological and endoscopic evaluation of the use of plasmutan in gastro-intestinal ulcerous diseases].
    Bergeron P; Gorce D; Tournier C; Tournut B
    Med Chir Dig; 1975; 4(4):264-5. PubMed ID: 1207205
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
    Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of peptic ulcer. Bismuth salts].
    Börsch G
    Verh Dtsch Ges Inn Med; 1988; 94():284-92. PubMed ID: 3061197
    [No Abstract]   [Full Text] [Related]  

  • 8. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
    Tripathi BM; Misra NP; Dube S
    J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of gastroduodenal ulcers through the combination calcium acexamate-light bismuth nitrate].
    Hureau J; Bourdais JP
    Med Chir Dig; 1973; 2(4):xxxi-xxxiv. PubMed ID: 4612265
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of gastroduodenal ulcer with plasmutan].
    Berard E; Gallavardin M
    Med Chir Dig; 1975; 4(1):57-60. PubMed ID: 1160427
    [No Abstract]   [Full Text] [Related]  

  • 11. [Colloidal bismuth subcitrate (de-nol) in the treatment of peptic ulcer].
    Grigo'rev PIa; Isakov VA; Iakovenko EP
    Klin Med (Mosk); 1989 May; 67(5):17-22. PubMed ID: 2671482
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of De-Nol].
    Tomecki R; Habior A; Medrzejewski W
    Pol Tyg Lek; 1984 Sep; 39(37):1247-8. PubMed ID: 6390386
    [No Abstract]   [Full Text] [Related]  

  • 13. An endoscopic evaluation of gastric ulcer treated with a mixture containing bismuth ammonium citrate.
    Lanza FL
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):779-88. PubMed ID: 4994682
    [No Abstract]   [Full Text] [Related]  

  • 14. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of colloidal bismuth and its combination with amoxicillin on the elimination of Helicobacter pylori in patients with a duodenal ulcer and chronic antral gastritis].
    Piubello W; Aimo G; Soldinger E; Pistoso S; Raggi G; Superti G; Bonesi R; Vitali E
    Recenti Prog Med; 1993 Jan; 84(1):40-4. PubMed ID: 8430249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of a bismuth aluminate antacid.
    Rider JA; Moeller HC; Gibbs JO; Puletti EJ; Desai DC
    Curr Ther Res Clin Exp; 1968 Mar; 10(3):109-15. PubMed ID: 4966996
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial.
    Wilson P; Alp MH
    Med J Aust; 1982 Mar; 1(5):222-3. PubMed ID: 7045603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.